Volume : 09, Issue : 07, July – 2022



Authors :

Kamlesh Kumar Pandey, Alok Pal Jain, Amit Nayak*

Abstract :

Objective: The objective of the paper was to synthesis and characterization of new isoxazole bearing pyrazole derivatives and evaluate them for antibacterial activity.
Material and methods: The isoxazole bearing pyrazole derivatives have been synthesized by the utilize the four-step process. Total Ten compounds have been synthesized and characterized by IR, 1HNMR, elemental and mass spectral analysis. The final compounds (PIA-1 to PIA-10) have been evaluated for antibacterial activity by disk diffusion method using sulfamethoxazole as standard drug.
Result and Discussion: The IR spectra of compound PIA-1 to PIA-10 shown the characteristics peak at 3052 (N-H), 2964 (C-H), 1628 (C=O), 1448 (C=N), 1625 (C=C), 1126 (C-O); 1015 (C-Br); 850 (C-Cl) and 1102 (C-F). The 1HNMR spectrum show the characteristics peak δ 6.68-6.70 (d, 2H, Ar-Fluorine), 7.14-7.16 (d, 1H, Ar-chlorine), 7.28-7.30 (m, 5H, Ar-H), 7.58-8.00 (d, 2H, Ar-Chlorine), 7.75-7.78 (d, 2H, Ar-Fluorine), 8.25 (s, 1H, Ar-H isoxazole), 10.97 (s, 1H, -Ar-H pyrazole); 7.26 (s, 1H, Ar-Cl). The antibacterial evaluation of the synthesized compounds stated that Isoxazole-pyrazole derivatives exhibit considerable inhibitory effect on all bacteria strains at both 50 µg/ml and 100 µg/ml dosing levels. PIA-1, PIA-2, PIA-3, PIA-4 had the highest activity in gram positive bacterial stains and PIA-1, PIA-3, PIA-4 and PIA-10 have shown best activity against gram negative bacteria.
Conclusion: The antibacterial activity of the synthesized compounds (PIA-1, PIA-3, PIA-4 and PIA-5) was significantly similar or better than that of standard Drug used for comparison. These Isoxazole bearing pyrazole compounds have demonstrated potency as a superior antibacterial agent, although more in-vivo research on the efficacy and dosage regimen of the compounds is needed.
Keywords: Antibacterial activity, Pyrazole, Isoxazole, sulfamethoxazole, disk diffusion

Cite This Article:

Please cite this article in press Kamlesh Kumar Pandey et al, Synthesis, Characterization And Pharmacological Evaluation Of Novel Isoxazole Bearing Pyrazole Derivatives For Antibacterial Activity., Indo Am. J. P. Sci, 2022; 09(7).,

Number of Downloads : 10


1. Rahmouni A, Romdhane A, Ben A, Vincent G, David T, Hichem BJ. Synthesis of novel isoxazolines and isoxazoles of N-substituted pyrazolo[3,4-d]pyrimidin-4(5H)-one derivatives through [3+2] cycloaddition. Arabian J Chem 2019; 12: 1974-1982.
2. Mohamed Zaki, Abdelouahd Oukhrib Mohamed Akssira, Sabine Berteina-Raboin. Synthesis of novel spiro-isoxazoline and spiro-isoxazolidine derivatives of tomentosin. RSC Adv 2017; 7: 6523-6529.
3. Reddy TS, Kulhari H, Reddy VG, Bansal V, Kamal A, Shukla R. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Eur J Med Chem 2015; 101: 790-805.
4. Vijesh AM, Isloor AM, Shetty P, Sundershan S, Fun HK. New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents. Eur J Med Chem 2013; 62: 410-415.
5. Siddiqui ZN, Farooq F, Musthafa TNM, Ahmad A, Khan AU. Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives. J Saudi Chem Soc 2013;17(2): 237-243.
6. Mekheimer RA, Ahmed EA, Sadek KU. Recent developments in the chemistry of pyrazolo[4,3-c]quinolines. Tetrahedron 2012; 68: 1637–1667.
7. Dadiboyena S, Nefzi A. Solid phase synthesis of isoxazole and isoxazoline-carboxamides via [2+3]-dipolar cycloaddition using resin-bound alkynes or alkenes. Tetrahedron Lett 2012; 53: 2096–2099.
8. Maheswari SU, Perumal S. A facile sequential threecomponent regio- and stereoselective synthesis of novel spiroisoxazoline/acridinone hybrids. Tetrahedron Lett 2012; 53: 6885–6888.
9. Farghaly TA, Abass IM, Abdalla MM, Mahgoub ROA. Synthesis and pharmacological activities of fused pyrimidinones. World J Chem 2011; 6: 8–18.
10. Shih SR, Chu TY, Reddy GR, Tseng SN, Chen HL, Tang WF, Wu MS, Yeh JY, Chao YS, Hsu JTA, Hsieh HP, Horng JT. Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J Biomed Sci 2010; 17(13): 1-9.
11. El-Enany MM, Kamel MM, Khalil OM, El-Nassan HB. Synthesis and antitumor activity of novel 6-aryl and 6-alkylpyrazolo[3,4-d]pyrimidin-4-one derivatives. Eur J Med Chem 2010; 45: 5286–5291.
12. Riyadh SM, Farghaly TA, Abdallah MA, Abdalla MM, Abd El-Aziz MR. New pyrazoles incorporating pyrazolylpyrazole moiety Synthesis, anti-HCV and antitumor activity. Eur J Med Chem 2010; 45: 1042–1050.
13. Conti P, Tamborini L, Pinto A, Sola L, Ettari R, Mercurio C, De Micheli C. Design and synthesis of novel isoxazole-based HDAC inhibitors. Eur J Med Chem 2010; 45: 4331–4338.
14. Dadiboyena S, Nefzi A. Recent methodologies toward the synthesis of valdecoxib: a potential 3,4-diarylisoxazolyl COX-II inhibitor. Eur J Med Chem 2010; 45: 4697–4707.
15. El-Enany MM, Kamel MM, Khalil OM, El-Nassan HB. Synthesis and antitumor activity of novel 6-aryl and 6-alkylpyrazolo[3,4-d]pyrimidin-4-one derivatives. Eur J Med Chem 2010; 45: 5286–5291
16. Youssef AM, Neeland EG, Villanueva EB, White MS, ElAshmawy IM, Patrick B, Klegeris A, Abd-El-Aziz AS. 2010. Synthesis and biological evaluation of novel pyrazole compounds. Bioorg Med Chem 2010; 18: 5685–5696.